Select for export Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/milmed/usac400 PubMed 36564939 Copy citation Copy BibTeX Military Medicine 2022-12-23 Joshua C. Gray, Mikela A. Murphy, Sierra Carter, Matthew W. Johnson, Aaron Wolfgang, Michael J. Roy OpenAlex Published psilocybin DepressionPTSDChronic Pain Other More
Select for export “A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0279073 PubMed 36516137 Copy citation Copy BibTeX PLoS ONE 2022-12-13 Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley OpenAlex Published psilocybin DepressionAddictionEmotional Processing Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export History of epilepsy increases risk of psychedelic-induced seizures Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.30967 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2022-12-09 Authors unavailable OpenAlex Published psilocybin DepressionAddictionPharmacology Observational Study More
Select for export Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1227/neu.0000000000002275 PubMed 36512813 Copy citation Copy BibTeX Unknown journal 2022-12-07 Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cpnec.2022.100163 PubMed 36545240 Copy citation Copy BibTeX Comprehensive Psychoneuroendocrinology 2022-12-05 Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Observational Study More
Select for export Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ijms232315284 PubMed 36499610 Copy citation Copy BibTeX International Journal of Molecular Sciences 2022-12-03 Błażej D. Pędzich, Mireia Medrano, An Buckinx, Ilse Smolders, Dimitri De Bundel OpenAlex Published psilocybin DepressionReceptor PharmacologyAnimal Study Animal Study More
Select for export Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0042-1759062 Copy citation Copy BibTeX Planta Medica 2022-11-30 Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos, K Ioannidis, V Mitsis, E Melliou OpenAlex Published psilocybinpsilocin DepressionAddictionEnd-of-Life Distress Clinical Trial More
Select for export A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability No abstract availability was recorded for this entry. Details DOI 10.1176/appi.ajp.22010073 PubMed 36453037 Copy citation Copy BibTeX American Journal of Psychiatry 2022-11-30 Gregory Barber, Charles B. Nemeroff, Steven Siegel OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1128/aem.01498-22 PubMed 36445079 Copy citation Copy BibTeX Applied and Environmental Microbiology 2022-11-28 Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, Dale L. Forrister, Jaclyn M. Winter, Laura Guzmán-Dávalos OpenAlex Published psilocybin DepressionPTSDEnd-of-Life Distress Other More
Select for export Fast and sustained effect of 2 administrations of psilocybin on depression No abstract availability was recorded for this entry. Details DOI 10.55788/0629715f Copy citation Copy BibTeX Unknown journal 2022-11-27 Marten Dooper OpenAlex Published psilocybin Depression Other More
Select for export Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221125354 PubMed 36433778 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-25 Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.31796 PubMed 36569662 Copy citation Copy BibTeX Unknown journal 2022-11-21 Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cbic.202200551 PubMed 36327140 Copy citation Copy BibTeX ChemBioChem 2022-11-21 Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D. Europe PMC Published psilocybin DepressionIn Vitro Study In Vitro Study More
Select for export NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-11-15 NWTraumatherapies ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionPTSDEnd-of-Life Distress Other More
Select for export Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/r96tc Copy citation Copy BibTeX PsyArXiv 2022-11-14 Guss J, Krause R, Sloshower J. PsyArXiv PREPRINT (not peer reviewed) psilocybin Depression Other More
Select for export Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2022-11-14 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin Depression Other More
Select for export A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-11-07 NYU Langone Health ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Other More
Select for export 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.11.03.515044 Copy citation Copy BibTeX bioRxiv 2022-11-02 Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyNeuroplasticity Animal Study More
Select for export Psilocybin reduces symptoms in treatment resistant depression, trial results show. No abstract availability was recorded for this entry. Details DOI 10.1136/bmj.o2623 PubMed 36411539 Copy citation Copy BibTeX BMJ 2022-11-01 Iacobucci G. Europe PMC Published psilocybin Depression Other More
